Bioventus Inc.
NASDAQ:BVS
11.69 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 512.345 | 512.117 | 430.898 | 321.161 | 340.141 | 319.177 | 292.059 | 274.5 | 253.65 | 242.893 | 232.375 | 64.774 |
| Kosten van de omzet
| 192.994 | 181.037 | 128.192 | 87.642 | 90.935 | 84.168 | 92.097 | 91.389 | 74.342 | 74.609 | 71.372 | 18.966 |
| Brutowinst
| 319.351 | 331.08 | 302.706 | 233.519 | 249.206 | 235.009 | 199.962 | 183.111 | 179.308 | 168.284 | 161.003 | 45.808 |
| Brutowinstmarge
| 0.623 | 0.646 | 0.703 | 0.727 | 0.733 | 0.736 | 0.685 | 0.667 | 0.707 | 0.693 | 0.693 | 0.707 |
| Onderzoek- en ontwikkelingskosten
| 13.446 | 25.941 | 19.039 | 11.202 | 11.055 | 8.095 | 8.096 | 7.9 | 14.747 | 9.465 | 10.936 | 4.665 |
| Algemene en administratieve kosten
| 286.041 | 327.403 | 250.38 | 190.309 | 196.124 | 0 | 0 | 0 | 0 | 0 | 0 | 33.916 |
| Verkoop- en marketingkosten
| 3.853 | 5.203 | 3.873 | 2.769 | 2.351 | 0 | 0 | 0 | 0 | 0 | 0 | 42.901 |
| Verkoop-, algemene en administratieve kosten
| 289.894 | 332.606 | 254.253 | 193.078 | 198.475 | 191.672 | 164.842 | 160.321 | 148.441 | 147.058 | 150.37 | 76.817 |
| Overige kosten
| 1.29 | 21.153 | 8.363 | 7.439 | 7.908 | -0.226 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bedrijfskosten
| 303.34 | 379.7 | 281.655 | 211.719 | 217.438 | 207.643 | 172.938 | 168.221 | 173.758 | 165.491 | 169.071 | 81.482 |
| Bedrijfsresultaat
| 16.011 | -35.676 | 17.722 | 21.237 | 31.193 | 25.504 | 27.024 | 14.89 | -16.588 | 0.02 | -8.068 | -35.674 |
| Bedrijfsresultaat ratio
| 0.031 | -0.07 | 0.041 | 0.066 | 0.092 | 0.08 | 0.093 | 0.054 | -0.065 | 0 | -0.035 | -0.551 |
| Totaal overige inkomsten en kosten netto
| -137.122 | -228.223 | -10.102 | -5.323 | -21.504 | -2.088 | -18.366 | -20.544 | -23.292 | -2.177 | -0.713 | -3.416 |
| Inkomen voor belasting
| -121.111 | -263.899 | 7.62 | 15.914 | 9.689 | 6.107 | 8.658 | -5.654 | -31.971 | -11.353 | -20.24 | -39.09 |
| Inkomen voor belasting ratio
| -0.236 | -0.515 | 0.018 | 0.05 | 0.028 | 0.019 | 0.03 | -0.021 | -0.126 | -0.047 | -0.087 | -0.603 |
| Belastingkosten
| 0.085 | -50.508 | -1.966 | 1.192 | 1.576 | 1.664 | -0.785 | 1.091 | 2.14 | 1.547 | 2.127 | 0.132 |
| Nettowinst
| -156.23 | -213.391 | 9.586 | 16.411 | 6.851 | -12.207 | -1.639 | -17.953 | -34.111 | -12.9 | -22.367 | -39.222 |
| Nettowinstmarge
| -0.305 | -0.417 | 0.022 | 0.051 | 0.02 | -0.038 | -0.006 | -0.065 | -0.134 | -0.053 | -0.096 | -0.606 |
| WPA (Winst Per Aandeel)
| -2.49 | -3.48 | 0.16 | 0.077 | -0.012 | -0.22 | -0.029 | -0.32 | -0.61 | -0.23 | -0.4 | 0 |
| Verwaterde WPA
| -2.49 | -3.48 | 0.16 | 0.077 | -0.012 | -0.22 | -0.029 | -0.32 | -0.61 | -0.23 | -0.4 | 0 |
| EBITDA
| 73.376 | 31.127 | 52.597 | 54.871 | 62.159 | 56.378 | 59.316 | 48.651 | 38.628 | 31.613 | 16.39 | -16.482 |
| EBITDA ratio
| 0.143 | 0.061 | 0.122 | 0.171 | 0.183 | 0.177 | 0.203 | 0.177 | 0.152 | 0.13 | 0.071 | -0.254 |